No press releases found.
Market Chameleon (Wed, 17-Dec 6:07 AM ET)
Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The four NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS11T, also referred to as NGC-Iri, is an analog of SN38, and PCS11T, PCS12852, and PCS499.
Processa Pharmaceuticals trades on the NASDAQ stock market under the symbol PCSA.
As of July 20, 2026, PCSA stock price declined to $2.23 with 11,495 million shares trading.
PCSA has a beta of 0.78, meaning it tends to be less sensitive to market movements. PCSA has a correlation of 0.00 to the broad based SPY ETF.
PCSA has a market cap of $6.17 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, PCSA traded as high as $18.00 and as low as $.11.
The top ETF exchange traded funds that PCSA belongs to (by Net Assets): VXF.
PCSA has outperformed the market in the last year with a price return of +950.9% while the SPY ETF gained +19.7%. However, in the short term, PCSA had mixed performance relative to the market. It has underperformed in the last 3 months, returning -28.1% vs +5.1% return in SPY. But in the last 2 weeks, PCSA shares have fared better than the market returning +3.2% compared to SPY -0.1%.
PCSA support price is $2.14 and resistance is $2.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PCSA shares will trade within this expected range on the day.
